SOURCE: Cryobanks International, Inc.

March 16, 2007 16:05 ET

Cryobanks International, Inc. Only Cord Blood Bank Accepting Donated Cord Blood Units Nationwide Year Round

ALTAMONTE SPRINGS, FL -- (MARKET WIRE) -- March 16, 2007 -- A number of states recently have announced legislative plans to address donation of umbilical cord blood. However, most do not have an in-state donation center or hospital to direct donations to. Since 1995, Cryobanks International, Inc. (CII) has been accepting and processing donated cord blood units from anywhere in the Continental United States. Fully accredited by the AABB and a member of the National Marrow Donor Program® Cord Blood Bank Network (NMDP), CII processes donated units following the highest standards in the industry. Units that qualify are listed on international registries so that anyone in need of a potential life-saving stem cell transplant may find an acceptable match.

CII works with the donor mother to manage the enrollment process providing qualified mothers with a proprietary collection kit to take with her to the hospital. CII then arranges for the return of the unit for processing following its strict guidelines and procedures. Finally, the unit is added to the registry system. The donation process is free to the donating family, takes only a few minutes to perform by their physician, and is painless to both mother and baby.

CII is currently working on an urgent nationwide effort to increase the numbers of donated cord blood units from several ethnic groups. To address this immediate need, CII is focusing on collecting cord blood units from the African American, Asian/Pacific Islander and Hispanic communities. This focused drive lasts through March 31st. Less than half of the cord blood units in the NMDP registry are from minority donors. Because tissue types are inherited, minority patients are more likely to match with units donated from a person of the same minority or ethnic background.

Anyone interested in helping educate mothers-to-be about donating their child's cord blood can contact CII at 800-869-8608 or visit If they are delivering before March 31st please contact the company immediately for more information.

About Cryobanks:

Cryobanks International is a corporation located in Altamonte Springs, Fl., which is to be acquired by BioStem, Inc. (OTCBB: BTEM). The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant. There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International is well poised to help meet that need, equipped with an inventory of over 9,000 cord blood units. For more information about Cryobanks International call 1-800-869-8608 or visit the website at

Safe Harbor Statement

This press release contains "forward-looking statements" by the Company. These statements relate to future events or financial performance and transactions, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements, to be materially different from those contemplated by the forward-looking statements. There can be no assurance that the acquisition described herein will successfully close. We undertake no ongoing obligation, other than that imposed by law, to update these statements. Factors that could affect results, levels of activity, performance or achievements and cause them to materially differ from those contained in the forward-looking statements include the failure to complete the merger of BioStem, Inc. (OTCBB: BTEM) and Cryobanks International, Inc., and other factors that can be found in BioStem's filings with the Securities and Exchange Commission, which can be found at

Contact Information